Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.

Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.

Item
http://www.wikidata.org/entity/Q35093640
Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case seriesConcordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targetsA small molecule agonist of an integrin, alphaLbeta2.Emerging drugs for moderate-to-severe psoriasis.Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series.Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.Antisense oligonucleotide treatments for psoriasis.Transition from methotrexate and cyclosporine to other therapies including retinoids, ultraviolet light and biologic agents in the management of patients with psoriasis.Protein-protein interactions as drug targets.Efalizumab: continuous therapy for chronic psoriasis.Update on the natural history and systemic treatment of psoriasis.Efalizumab discontinuation: a practical strategy.Aplastic anemia: immunosuppressive therapy in 2010.LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20.
P2860

Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.

Item
http://www.wikidata.org/entity/Q35093640
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.
@ast
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.
@en
type
label
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.
@ast
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.
@en
prefLabel
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.
@ast
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698